查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942795

2026年全球电子药物传输系统市场报告

Electronic Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，电子药物输送系统市场规模显着成长，预计将从2025年的119.3亿美元成长到2026年的131.1亿美元，复合年增长率达9.9%。过去几年的成长可归因于多种因素，例如慢性病盛行率上升、注射和吸入疗法的推广、输液疗法的使用增加、居家医疗的普及以及电子药物输送平台的广泛应用。

预计未来几年，电子药物输送系统市场将快速成长，到2030年市场规模将达到194.4亿美元，复合年增长率（CAGR）为10.4%。预测期内的成长要素包括：对个人化药物输送的需求不断增长、数位健康生态系统的日益普及、远端患者监护的扩展、对基于依从性的治疗结果的日益关注，以及基于人工智慧的给药演算法的日益整合。预测期内的主要趋势包括：智慧型药物输送设备的日益普及、互联可穿戴输送系统的日益整合、精准给药控制技术的日益广泛应用、以患者为中心的自我给药设备的扩展，以及对治疗依从性监测的日益重视。

电子药物输送系统市场预计将因慢性病盛行率的不断上升而成长。持续一年以上且需要长期治疗的慢性病患者可受益于电子药物传输系统，有助于调整和监测药物剂量。例如，根据美国国家医学图书馆2023年1月发布的报告，到2050年，美国50岁及以上至少有一种慢性病的人口预计将达到1.4266亿。慢性病盛行率的上升趋势预计将进一步增加对电子药物传输系统的需求。

电子药物管理系统市场的主要企业正致力于创新解决方案，例如可重复使用的电子注射平台，以提高给药准确性、患者依从性和永续性。可重复使用的电子注射平台是电池供电的多用途智慧设备，能够实现精准给药，同时追踪用药情况并支持患者依从性。例如，2025年1月，美国医疗设备製造商Portal Instruments Inc.发布了PRIME Nexus，这是一款可重复使用的电子注射平台，旨在提高注射给药的准确性、通用性和可持续性。本系统相容于多种规格的药物容器，包括1毫升和2.25毫升预填充式注射器以及3毫升药筒，并可处理黏度高达600 cP的高黏度製剂。它具有可程式设计注射控制功能，并可选配连接功能，用于监测用药依从性并与医疗保健提供者共用数据。其可重复使用的设计减少了医疗废弃物，降低了整体注射成本，从而支持永续性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球电子药物输送系统市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
  • 主要趋势
    • 智慧型药物传输装置的应用日益普及
    • 互联可穿戴药物输送系统正变得越来越一体化
    • 扩大精准剂量控制技术的应用
    • 扩展以病人为中心的自我管理设备
    • 更重视治疗依从性监测。

第五章 终端用户产业市场分析

  • 医院
  • 居家医疗保健服务提供者
  • 专科诊所
  • 门诊治疗中心
  • 药局

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球电子药物输送系统市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球电子药物传输系统市场规模、比较及成长率分析
  • 全球电子药物传输系统市场表现：规模与成长，2020-2025年
  • 全球电子药物传输系统市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 电子输液帮浦、电子注射笔、电子自动注射器、电子吸入器、电子胶囊
  • 按组件
  • 感测器、无线通讯设备和天线、微型泵浦和流量调节器、药物储库、微控制器及其他组件
  • 依系统类型
  • 电池供电系统，可充电系统
  • 透过分销管道
  • 医院药房、零售药房
  • 透过使用
  • 糖尿病、心血管疾病、呼吸系统疾病、多发性硬化症等用途
  • 按类型细分：电子输液泵
  • 容积式输液帮浦、注射式输液帮浦、携带式输液帮浦
  • 按类型细分：电子注射笔
  • 胰岛素笔、生长激素笔和其他注射式药物笔
  • 按类型细分：电子自动注射器
  • 预填充自动注射器，弹簧式自动注射器
  • 按类型细分：电子吸入器
  • 定量吸入器（MDI）、干粉吸入器（DPI）、缓雾吸入器
  • 按类型细分：电子胶囊
  • 智慧胶囊，带感测器的数位胶囊

第十章 区域与国家分析

  • 全球电子药物输送系统市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球电子药物输送系统市场：依国家划分、绩效及预测（2020-2025年、2025-2030年预测、2035年预测）

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 电子药物输送系统市场：竞争格局及市场占有率（2024 年）
  • 电子药物输送系统市场：公司估值矩阵
  • 电子药物输送系统市场：公司概况
    • Medtronic plc
    • Novo Nordisk A/S
    • Insulet Corporation
    • Tandem Diabetes Care Inc.
    • United Therapeutics Corporation

第37章：其他领先和创新企业

  • Sanofi SA, Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z oo, HCmed Innovations Co. Ltd, Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年电子药物输送系统市场：提供新机会的国家
  • 电子药物输送系统市场展望（2030）：新兴细分市场机会
  • 电子药物输送系统市场展望（2030 年）：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MEDDS01_G26Q1

Electronic drug delivery systems encompass devices or formulations designed to facilitate the targeted delivery of a medical substance to a specific region while avoiding non-target cells and tissues. These systems ensure the controlled administration of drugs, allowing for easy monitoring of doses.

The primary categories of electronic drug delivery systems include electronic infusion pumps, electronic injection pens, electronic auto-injectors, electronic inhalers, electronic capsules, and other variants. Electronic infusion pumps are medical devices that regulate the controlled delivery of fluids into a patient's body. Deployed in healthcare settings such as hospitals and nursing homes, these pumps are instrumental in delivering fluids such as nutrients and medications. Essential components of electronic drug delivery systems comprise sensors, wireless communicators, antennas, micro-pumps, flow regulators, drug reservoirs, microcontrollers, and other elements, available in both battery-powered and rechargeable systems. These electronic drug delivery systems are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to the treatment of various conditions such as diabetes, cardiovascular disease, respiratory disorders, multiple sclerosis, and other ailments.

Tariffs are impacting the electronic drug delivery systems market by increasing costs of imported sensors, microcontrollers, batteries, wireless modules, and precision pumps used in smart delivery devices. Pharmaceutical and medical device manufacturers in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device assembly. These tariffs are increasing production costs and device pricing. However, they are also encouraging domestic component sourcing, local assembly, and innovation in cost-efficient electronic drug delivery solutions.

The electronic drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides electronic drug delivery systems market statistics, including electronic drug delivery systems industry global market size, regional shares, competitors with a electronic drug delivery systems market share, detailed electronic drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the electronic drug delivery systems industry. This electronic drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $11.93 billion in 2025 to $13.11 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of injectable and inhalable therapies, increasing use of infusion-based treatments, growth in home healthcare adoption, availability of electronic drug delivery platforms.

The electronic drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $19.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for personalized drug delivery, rising adoption of digital health ecosystems, expansion of remote patient monitoring, growing focus on adherence-driven outcomes, increasing integration of ai-based dosing algorithms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising integration of connected and wearable delivery systems, growing use of precision dose control technologies, expansion of patient-centric self-administration devices, enhanced focus on therapy adherence monitoring.

The anticipated growth of the electronic drug delivery systems market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for more than a year and necessitating ongoing medical treatment, can benefit from electronic drug delivery systems that aid in regulating and monitoring drug doses. For example, in January 2023, the National Library of Medicine reported that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million by 2050. This upward trend in chronic diseases is poised to fuel the demand for electronic drug delivery systems.

Major companies in the electronic drug delivery systems market are increasingly focusing on innovative solutions, such as reusable electronic injector platforms, to improve dosing accuracy, patient adherence, and sustainability. Reusable electronic injector platforms are battery-powered, smart devices designed for multiple uses, delivering precise medication doses while tracking usage and supporting adherence. For example, in January 2025, Portal Instruments Inc., a US-based medical device company, launched the PRIME Nexus, a reusable electronic injector platform engineered to enhance the administration of injectable medications with improved precision, versatility, and sustainability. The system accommodates multiple drug container sizes, including 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and can handle high-viscosity formulations up to 600 cP. It provides programmable injection control and optional connectivity for adherence monitoring and data sharing with healthcare providers. Its reusable design supports sustainability by reducing medical waste and lowering overall injection costs.

In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to strengthen its central nervous system (CNS) drug delivery capabilities and expand its pipeline of targeted therapies. Alcyone Therapeutics Inc., a US-based healthcare technology company, specializes in developing advanced drug delivery platforms designed to enhance precision and efficacy in the treatment of neurological disorders.

Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.

North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the electronic drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The electronic drug delivery systems market consists of sales of nasal sprays, eyedroppers, and intrauterine devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electronic Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses electronic drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for electronic drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Electronic Infusion Pumps; Electronic Injection Pens; Electronic Auto-Injectors; Electronic Inhalers; Electronic Capsules
  • 2) By Component: Sensors; Wireless Communicator And Antennas; Micro Pumps And Flow Regulators; Drug Reservoir; Microcontroller; Other Components
  • 3) By System Type: Battery-Powered Systems; Rechargeable Systems
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
  • 5) By Application: Diabetes; Cardiovascular Disease; Respiratory Disorders; Multiple Sclerosis; Other Applications
  • Subsegments:
  • 1) By Electronic Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps
  • 2) By Electronic Injection Pens: Insulin Pens; Growth Hormone Pens; Other Injectable Medication Pens
  • 3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors; Spring-Loaded Auto-Injectors
  • 4) By Electronic Inhalers: Metered Dose Inhalers (MDI); Dry Powder Inhalers (DPI); Soft Mist Inhalers
  • 5) By Electronic Capsules: Smart Capsules; Digital Capsules With Sensors
  • Companies Mentioned: Medtronic plc; Novo Nordisk A/S; Insulet Corporation; Tandem Diabetes Care Inc.; United Therapeutics Corporation; Sanofi S.A.; Abbott Laboratories; Roche Holding AG; Johnson & Johnson; Bayer AG; Antares Pharma Inc.; CeQur Corporation; BIOCORP; Adherium Limited; Amiko Digital Health Limited; FindAir Sp. z o.o.; HCmed Innovations Co. Ltd.; Insulet International Limited; Ypsomed Holding AG; Enable Injections Inc.; Eitan Medical Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Electronic Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Electronic Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Electronic Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Electronic Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Smart Drug Delivery Devices
    • 4.2.2 Rising Integration Of Connected And Wearable Delivery Systems
    • 4.2.3 Growing Use Of Precision Dose Control Technologies
    • 4.2.4 Expansion Of Patient-Centric Self-Administration Devices
    • 4.2.5 Enhanced Focus On Therapy Adherence Monitoring

5. Electronic Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Home Healthcare Providers
  • 5.3 Specialty Clinics
  • 5.4 Ambulatory Care Centers
  • 5.5 Pharmacies

6. Electronic Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Electronic Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Electronic Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Electronic Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Electronic Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Electronic Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Electronic Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Electronic Drug Delivery Systems Market Segmentation

  • 9.1. Global Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules
  • 9.2. Global Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
  • 9.3. Global Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Battery-Powered Systems, Rechargeable Systems
  • 9.4. Global Electronic Drug Delivery Systems Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies
  • 9.5. Global Electronic Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
  • 9.6. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Infusion Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
  • 9.7. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Injection Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
  • 9.8. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Auto-Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
  • 9.9. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
  • 9.10. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Capsules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Smart Capsules, Digital Capsules With Sensors

10. Electronic Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Electronic Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Electronic Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Electronic Drug Delivery Systems Market

  • 11.1. Asia-Pacific Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Electronic Drug Delivery Systems Market

  • 12.1. China Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Electronic Drug Delivery Systems Market

  • 13.1. India Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Electronic Drug Delivery Systems Market

  • 14.1. Japan Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Electronic Drug Delivery Systems Market

  • 15.1. Australia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Electronic Drug Delivery Systems Market

  • 16.1. Indonesia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Electronic Drug Delivery Systems Market

  • 17.1. South Korea Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Electronic Drug Delivery Systems Market

  • 18.1. Taiwan Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Electronic Drug Delivery Systems Market

  • 19.1. South East Asia Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Electronic Drug Delivery Systems Market

  • 20.1. Western Europe Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Electronic Drug Delivery Systems Market

  • 21.1. UK Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Electronic Drug Delivery Systems Market

  • 22.1. Germany Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Electronic Drug Delivery Systems Market

  • 23.1. France Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Electronic Drug Delivery Systems Market

  • 24.1. Italy Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Electronic Drug Delivery Systems Market

  • 25.1. Spain Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Electronic Drug Delivery Systems Market

  • 26.1. Eastern Europe Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Electronic Drug Delivery Systems Market

  • 27.1. Russia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Electronic Drug Delivery Systems Market

  • 28.1. North America Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Electronic Drug Delivery Systems Market

  • 29.1. USA Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Electronic Drug Delivery Systems Market

  • 30.1. Canada Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Electronic Drug Delivery Systems Market

  • 31.1. South America Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Electronic Drug Delivery Systems Market

  • 32.1. Brazil Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Electronic Drug Delivery Systems Market

  • 33.1. Middle East Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Electronic Drug Delivery Systems Market

  • 34.1. Africa Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Electronic Drug Delivery Systems Market Regulatory and Investment Landscape

36. Electronic Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Electronic Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Electronic Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Electronic Drug Delivery Systems Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Tandem Diabetes Care Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. United Therapeutics Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Electronic Drug Delivery Systems Market Other Major And Innovative Companies

  • Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o, HCmed Innovations Co. Ltd, Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc

38. Global Electronic Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Electronic Drug Delivery Systems Market

40. Electronic Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Electronic Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Electronic Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Electronic Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer